Published in Crit Care Med on December 01, 2009
Hospital admission decision for patients with community-acquired pneumonia: variability among physicians in an emergency department. Ann Emerg Med (2011) 1.10
Mortality, morbidity, and disease severity of patients with aspiration pneumonia. J Hosp Med (2012) 0.96
Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care (2012) 0.95
Nonlinear Imputation of Pao2/Fio2 From Spo2/Fio2 Among Patients With Acute Respiratory Distress Syndrome. Chest (2016) 0.87
Validating hospital admission criteria for decision support in pneumonia. BMC Pulm Med (2014) 0.84
Minor criteria of Infectious Disease Society Of America/American Thoracic Society for severe community-acquired pneumonia can predict delayed treatment response. J Korean Med Sci (2012) 0.79
Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia. Cell Biol Toxicol (2016) 0.79
Epidemiology and outcome of sepsis in adult patients with Streptococcus pneumoniae infection in a Norwegian county 1993-2011: an observational study. BMC Infect Dis (2016) 0.78
Defining and predicting severe community-acquired pneumonia. Curr Opin Infect Dis (2010) 0.78
Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia. Respirology (2012) 0.77
Defining severe pneumonia. Clin Chest Med (2011) 0.77
Triaging severe pneumonia: what is the "score" on prediction rules? Crit Care Med (2009) 0.77
CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting. Eur J Clin Microbiol Infect Dis (2012) 0.77
Management of severe community-acquired pneumonia in Brazil: a secondary analysis of an international survey. Rev Bras Ter Intensiva (2015) 0.75
Severe community-acquired pneumonia: timely management measures in the first 24 hours. Crit Care (2016) 0.75
Is area under receiver operator characteristic curve the best way of comparing severity assessment tools for patients with community-acquired pneumonia? Crit Care Med (2010) 0.75
Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study. Crit Care Med (2017) 0.75
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (1994) 27.36
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med (1999) 18.50
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax (2003) 9.54
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 9.08
Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med (1997) 4.84
Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med (2006) 4.24
Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med (2002) 3.78
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis (1993) 3.68
Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual (2005) 3.43
Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10 (1999) 2.81
Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest (2007) 2.58
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis (2008) 2.56
Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA (1989) 2.53
Severity prediction rules in community acquired pneumonia: a validation study. Thorax (2000) 2.14
A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest (2007) 2.14
Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med (1998) 1.99
Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest (2006) 1.83
Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med (2002) 1.78
Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual (1997) 1.71
Severe community-acquired pneumonia in ICUs: prospective validation of a prognostic score. Intensive Care Med (1996) 1.69
Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax (2004) 1.68
A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax (2006) 1.62
International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol (2007) 1.58
Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients. J Clin Epidemiol (2006) 1.45
A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med (1995) 1.32
Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis (2001) 1.30
Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med (2001) 1.25
The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service. Respir Med (1992) 1.19
A population-based study of the costs of care for community-acquired pneumonia. Eur Respir J (2004) 1.14
Pneumonia and influenza death rates--United States, 1979-1994. MMWR Morb Mortal Wkly Rep (1995) 1.14
Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest (2000) 1.10
Validation of the 2001 American Thoracic Society criteria for severe community-acquired pneumonia. Crit Care Med (2004) 1.08
Recognising severe pneumonia with simple clinical and biochemical measurements. Clin Med (2003) 1.07
Electronic screening of dictated reports to identify patients with do-not-resuscitate status. J Am Med Inform Assoc (2004) 1.03
Local guidelines for community-acquired pneumonia: development, implementation, and outcome studies. Infect Dis Clin North Am (2004) 0.91
Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy. Curr Opin Infect Dis (2001) 0.88
Predicting need for ICU in community-acquired pneumonia. Chest (2008) 0.82
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest (2009) 3.70
Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci (2005) 3.53
Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual (2005) 3.43
A modified sequential organ failure assessment score for critical care triage. Disaster Med Public Health Prep (2010) 2.28
Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc Natl Acad Sci U S A (2009) 2.20
Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep. J Neurosci (2005) 2.12
Performance and utilization of an emergency department electronic screening tool for pneumonia. JAMA Intern Med (2013) 1.95
Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons. Eur J Neurosci (2008) 1.74
Orexin and MCH neurons express c-Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors. Eur J Neurosci (2005) 1.55
Discharge profiles of identified GABAergic in comparison to cholinergic and putative glutamatergic basal forebrain neurons across the sleep-wake cycle. J Neurosci (2009) 1.54
The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. J Neurosci (2003) 1.43
Sleep-wake related discharge properties of basal forebrain neurons recorded with micropipettes in head-fixed rats. J Neurophysiol (2004) 1.42
Parvalbumin, calbindin, or calretinin in cortically projecting and GABAergic, cholinergic, or glutamatergic basal forebrain neurons of the rat. J Comp Neurol (2003) 1.33
Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins. J Comp Neurol (2006) 1.23
Activity profiles of cholinergic and intermingled GABAergic and putative glutamatergic neurons in the pontomesencephalic tegmentum of urethane-anesthetized rats. J Neurosci (2009) 1.22
Discharge profiles across the sleep-waking cycle of identified cholinergic, GABAergic, and glutamatergic neurons in the pontomesencephalic tegmentum of the rat. J Neurosci (2014) 1.21
GABAergic neurons intermingled with orexin and MCH neurons in the lateral hypothalamus discharge maximally during sleep. Eur J Neurosci (2010) 1.17
Addiction and arousal: alternative roles of hypothalamic peptides. J Neurosci (2006) 1.14
Rhythmically discharging basal forebrain units comprise cholinergic, GABAergic, and putative glutamatergic cells. J Neurophysiol (2003) 1.14
Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J Neurosci (2002) 1.12
Hospital admission decision for patients with community-acquired pneumonia: variability among physicians in an emergency department. Ann Emerg Med (2011) 1.10
Validation of the 2001 American Thoracic Society criteria for severe community-acquired pneumonia. Crit Care Med (2004) 1.08
Muscarinic-2 and orexin-2 receptors on GABAergic and other neurons in the rat mesopontine tegmentum and their potential role in sleep-wake state control. J Comp Neurol (2008) 1.06
Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci (2004) 1.05
Electronic screening of dictated reports to identify patients with do-not-resuscitate status. J Am Med Inform Assoc (2004) 1.03
Nicotinic enhancement of the noradrenergic inhibition of sleep-promoting neurons in the ventrolateral preoptic area. J Neurosci (2004) 1.02
c-Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum after paradoxical sleep deprivation and recovery. Eur J Neurosci (2002) 0.99
Vesicular glutamate (VGlut), GABA (VGAT), and acetylcholine (VACht) transporters in basal forebrain axon terminals innervating the lateral hypothalamus. J Comp Neurol (2006) 0.99
Mortality, morbidity, and disease severity of patients with aspiration pneumonia. J Hosp Med (2012) 0.96
Alpha 2 adrenergic receptors on GABAergic, putative sleep-promoting basal forebrain neurons. Eur J Neurosci (2003) 0.91
Dynamic changes in GABAA receptors on basal forebrain cholinergic neurons following sleep deprivation and recovery. BMC Neurosci (2007) 0.90
Characteristics associated with clinician diagnosis of aspiration pneumonia: a descriptive study of afflicted patients and their outcomes. J Hosp Med (2014) 0.86
Validating hospital admission criteria for decision support in pneumonia. BMC Pulm Med (2014) 0.84
Admission decisions and outcomes of community-acquired pneumonia in the homeless population: a review of 172 patients in an urban setting. Am J Public Health (2013) 0.84
Sleep-deprivation regulates α-2 adrenergic responses of rat hypocretin/orexin neurons. PLoS One (2011) 0.82
Rat hypocretin/orexin neurons are maintained in a depolarized state by TRPC channels. PLoS One (2010) 0.82
Technology implementation impacting the outcomes of patients with CAP. Semin Respir Crit Care Med (2012) 0.79
Suprachiasmatic modulation of noradrenaline release in the ventrolateral preoptic nucleus. J Neurosci (2007) 0.78
Defining and predicting severe community-acquired pneumonia. Curr Opin Infect Dis (2010) 0.78
Empiric antibiotic selection and risk prediction of drug-resistant pathogens in community-onset pneumonia. Curr Opin Infect Dis (2016) 0.77
Defining severe pneumonia. Clin Chest Med (2011) 0.77
Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia. Respirology (2012) 0.77
The unintended, negative consequences of the door-to-antibiotic measure for pneumonia. Ann Intern Med (2009) 0.75
Horses and Zebras: complex cardiac anatomy in a patient with out-of-hospital cardiac arrest. Crit Ultrasound J (2011) 0.75
Encouraging news from the antibiotic resistance front. Chest (2003) 0.75
Somatostatin varicosities contain the vesicular GABA transporter and contact orexin neurons in the hypothalamus. Eur J Neurosci (2012) 0.75